Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral theophylline for complications caused by double J ureteral stents
IRCT20190624043991N22Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of theophylline in ureterolithiasis, sponsored by Tehran University of Medical Sciences. Started Jan 2024; status: completed.
02
Drugs
theophylline
03
Conditions
ureterolithiasis
Beyond the preview
Go deeper on IRCT20190624043991N22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190624043991N22.